INTACT BREAST LESION EXCISION SYSTEM AND ADVANCE

Instrument, Biopsy

INTACT MEDICAL CORPORATION

The following data is part of a premarket notification filed by Intact Medical Corporation with the FDA for Intact Breast Lesion Excision System And Advance.

Pre-market Notification Details

Device IDK060413
510k NumberK060413
Device Name:INTACT BREAST LESION EXCISION SYSTEM AND ADVANCE
ClassificationInstrument, Biopsy
Applicant INTACT MEDICAL CORPORATION ONE APPLE HILL SUITE 316 Natick,  MA  01760
ContactDavid Jacobs
CorrespondentDavid Jacobs
INTACT MEDICAL CORPORATION ONE APPLE HILL SUITE 316 Natick,  MA  01760
Product CodeKNW  
CFR Regulation Number876.1075 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2006-02-16
Decision Date2006-04-27
Summary:summary

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.